Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 15.1 USD 0.73%
Updated: May 20, 2024

Entrada Therapeutics Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Entrada Therapeutics Inc
Short-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Entrada Therapeutics Inc
NASDAQ:TRDA
Short-Term Investments
$284.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$2m
CAGR 3-Years
-55%
CAGR 5-Years
-64%
CAGR 10-Years
-46%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
$1B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$7.9B
CAGR 3-Years
56%
CAGR 5-Years
39%
CAGR 10-Years
46%

See Also

What is Entrada Therapeutics Inc's Short-Term Investments?
Short-Term Investments
284.4m USD

Based on the financial report for Dec 31, 2023, Entrada Therapeutics Inc's Short-Term Investments amounts to 284.4m USD.

What is Entrada Therapeutics Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 1Y
98%

Over the last year, the Short-Term Investments growth was 98%.